IDH1 and cancer: However, since the enzyme kinetic results were different between G98N and R133H and the corresponding human enzymes, it seems unlikely that C. elegans would serve as a good model specifically for human cancers involving IDH1 mutations or for developing drugs that bind to IDH1.